Bilateral Lumbar Decompression Via Uniportal Endoscopic Laminotomy in Patients With Lumbar Spinal Stenosis: Multicentric Case Series
Key facts
- Who runs it
- TecSalud Investigación Clínica
- Where
- Mexico1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Recruiting
- People taking part
- 78 people, planned
- Started
- 25 Feb 2026
- Expected to end
- Jul 2027
- Type of study
- Observational
- Treatments tested
- Unilateral Laminotomy with Bilateral Lumbar Decompression (ULBLD)
- Record updated
- 4 March 2026
Who can take part
- Age
- 18 years to 74 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
Show the full registry criteria (13)Hide the full registry criteria
Who can take part
- Provision of informed consent to participate in the study
- Age ≥18 years and <75 years
- Patients with lumbar spinal stenosis grade I-III according to the Lee scale
- Radicular or myelopathic symptoms
- Having undergone complete conservative management, including physical therapy and analgesia, for at least 3 months
- Patients who have opted for ULBLD using endoscopic uniportal technique for lumbar spinal stenosis
Who cannot take part
- Prior lumbar surgeries at the levels to be treated
- Infectious symptoms or concomitant rheumatologic diseases
- Inability to read or write
- Criteria of lumbar vertebral instability
- Congenital spinal malformations
- Disc herniation at the same lumbar level to be operated on
- Medullary hyperintensity on T2-weighted magnetic resonance imaging in the levels to be treated
Eligibility questionnaire
From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Age
- Spinal stenosis lumbar
This trial is currently available in Mexico.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Lumbar spinal stenosis is a condition that can cause pain, sensory disturbances, and motor deficits due to the compression of neural structures in the lumbar spine. While conservative treatments such as physical therapy and pain management can help some patients, others with persistent neurological deficits may require surgical intervention. Traditional surgical approaches, including open laminectomy, have proven effective but carry risks such as extensive muscle damage, considerable blood loss, postoperative spinal instability, and prolonged recovery times.
Read full original descriptionShow less
This study evaluates a minimally invasive surgical approach called unilateral laminotomy with bilateral lumbar decompression (ULBLD) using endoscopic uniportal technique as an alternative to traditional methods for patients with lumbar spinal stenosis. The main objective is to assess changes in neurological deficits and disability in patients with lumbar spinal stenosis following this procedure. The study will also document hospitalization duration, surgical time, blood loss, and the incidence of postoperative complications.
This multicenter, prospective case series will recruit 78 patients from three medical centers in Mexico. Participants must have symptomatic lumbar spinal stenosis that persists despite at least three months of conservative treatment. Eligible patients will undergo ULBLD using endoscopic uniportal technique, a method that allows precise nerve decompression through a small incision, minimizing damage to surrounding tissues. Standardized clinical assessment tools, including the Japanese Orthopaedic Association (JOA) scale for lumbar disease, Oswestry Disability Index (ODI), and Visual Analog Scale (VAS) for pain, will be used to evaluate outcomes at multiple time points over 12 months.
By comparing patients' preoperative and postoperative evaluations, the study aims to determine whether ULBLD using endoscopic uniportal technique effectively improves neurological function and reduces disability while maintaining a favorable safety profile. Findings from this study could lead to a more precise understanding of the impact of ULBLD on disability, pain, and health-related quality of life for patients with lumbar spinal stenosis.
The group in the trial
- Lumbar Spinal Stenosis Cases
Patients diagnosed with lumbar spinal stenosis who exhibit persistent neurological deficits and pain despite receiving at least three months of conservative treatment. All participants have elected to undergo ULBLD using endoscopic uniportal technique. They are being prospectively followed to evaluate improvements in neurological function and reductions in pain-related disability, as well as to document perioperative outcomes including surgical time, blood loss, hospital stay, and complications.
Treatment: Unilateral Laminotomy with Bilateral Lumbar Decompression (ULBLD)
Next steps
For your doctor
Doctor ask sheet
A PDF for your doctor: what this trial tests, who can take part, and 2 eligibility questions with room for answers and notes.
PDF, US Letter, 1 to 2 pages. A4 size
For the study team
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Criteria questions
- Built from NCT07045714, who can take part
- Record updated
- 4 March 2026